ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Letter: ORI And Plotkin Should Release Report

June 23, 1995

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

October 22, 2004

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

Newell Reports Cancer Deaths In Younger Age Groups Dropping

March 18, 1977

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978